Please login to the form below

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market. Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE listing




Below are full profiles from other companies in this area

Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our collaborative cross-discipline approach enables us to create engaging, effective and measurable campaigns across channels to deliver distinctive solutions at every stage of a product’s lifecycle.

View profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View profile

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Company Details

The Clinical Trial Company

Telephone:+44 1565 733 772

Address:
Mere View Barn
Park Lane , Pickmere
Knutsford
WA16 0LG
UK

Latest content from PMHub

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access.
PRMA Consulting Ltd
Cello Health Acquire ISS
Acquisition further strengthens technical advisory services in US Cello Health
Putting our core values into practice at the Porterhouse summer social
Porterhouse Medical Group
CMR celebrates successful Management Buyout
CEO of Creative Medical Research (CMR), George Ashford, has successfully completed a management buyout. Creative Medical Research